Home/Filings/4/0001181431-12-036820
4//SEC Filing

ROE WAYNE I 4

Accession 0001181431-12-036820

CIK 0000930553other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:01 PM ET

Size

25.2 KB

Accession

0001181431-12-036820

Insider Transaction Report

Form 4
Period: 2012-06-06
ROE WAYNE I
Director
Transactions
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0616,0000 total
    Exercise: $6.08Exp: 2016-10-19Common Stock (16,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0616,2500 total
    Exercise: $6.96Exp: 2013-09-10Common Stock (16,250 underlying)
  • Disposition to Issuer

    Common Stock

    2012-06-06$9.10/sh38,558$350,8780 total
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0616,0000 total
    Exercise: $5.82Exp: 2015-10-13Common Stock (16,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-069,0000 total
    Exercise: $10.75Exp: 2014-10-20Common Stock (9,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0620,0000 total
    Exercise: $4.58Exp: 2020-12-06Common Stock (20,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0620,0000 total
    Exercise: $4.72Exp: 2019-12-07Common Stock (20,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0620,0000 total
    Exercise: $3.89Exp: 2021-12-05Common Stock (20,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0611,1000 total
    Exercise: $0.79Exp: 2018-12-10Common Stock (11,100 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0611,1000 total
    Exercise: $6.90Exp: 2017-10-11Common Stock (11,100 underlying)
Footnotes (10)
  • [F1]Disposed of pursuant to agreement and plan of merger by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger.
  • [F10]The option which was fully vested on 09/10/04 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.14 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F2]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.21 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F3]The option which was fully vested on 12/06/11 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.52 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F4]The option which was fully vested on 12/07/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.38 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F5]The option which was fully vested on 12/10/09 was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.31 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F6]The option which was fully vested on 10/11/08 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.20 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F7]The option which was fully vested on 10/19/07 was cancelled in the Merger Agreement in exchange for a cash payment equal to $3.02 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F8]The option which was fully vested on 10/13/06 was cancelled in the Merger Agreement in exchange for a cash payment equal to $3.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F9]The option which was fully vested on 10/20/05 was cancelled in the Merger Agreement.

Issuer

ISTA PHARMACEUTICALS INC

CIK 0000930553

Entity typeother

Related Parties

1
  • filerCIK 0001216990

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:01 PM ET
Size
25.2 KB